ArticleJCO oncology practice2025

Real-World Evidence of Combination Therapy Use in Metastatic Hormone-Sensitive Prostate Cancer in the United States From 2017 to 2023.

Amit D Raval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.